CNE100002Z24
CNE100002Z24
DALIAN BIO-CHEM CO LTD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 8.47B EUR | 11.5B EUR | 18.93B EUR | 22.75B EUR |
Enterprise Value | 9.28B EUR | 11.91B EUR | 19.19B EUR | 22.93B EUR |
Valuation Multiples | ||||
Trailing P/E | 48x | 80.83x | 135.94x | 128.87x |
Forward P/E | 12.5x | -- | -- | -- |
Price to Sales | 5.6x | 9.53x | 15.9x | 16.06x |
Price to Book | 5.89x | 8.19x | 13.43x | 16.39x |
EV/Revenue | 6.13x | 9.87x | 16.11x | 16.18x |
EV/EBITDA | 24.31x | 49.3x | 72.36x | 68.92x |
Price to FCF (P/FCF) | 22.16x | 50.77x | 54.38x | 71.22x |
EV/FCF | 24.26x | 52.58x | 55.11x | 71.75x |
FCF Yield | 4.51% | 1.97% | 1.84% | 1.4% |